SCHEMBL5100129

SCHEMBL5100129

O=C(c1cccc2cccnc12)N1CCN(CCc2ccc(F)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.56
HTR2C P28335 4/20 0.56
DRD4 P21917 1/20 0.53
SLC6A2 P23975 1/20 0.53
HTR1D P28221 1/20 0.53
SLC6A4 P31645 1/20 0.53
HTR7 P34969 1/20 0.53
HTR2B P41595 1/20 0.53
TMEM97 Q5BJF2 1/20 0.53
SIGMAR1 Q99720 1/20 0.53
PRKAA2 P54646 1/20 0.50
POLB P06746 1/20 0.49
GAA P10253 1/20 0.49
APP P05067 1/20 0.48
THRB P10828 1/20 0.47
KCNH2 Q12809 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23775498 0.82 HTR2A (0.51) HTR2AHTR2CTMEM97SIGMAR1THRB
SCHEMBL6251264 0.79 PRKAA2 (0.56) HTR2AHTR2CPRKAA2THRBKCNH2
SCHEMBL5278050 0.78 HTR2A (0.63) HTR2AHTR2CDRD4SLC6A2HTR1D
SCHEMBL2548790 0.77 HTR2A (0.75) HTR2AHTR2CDRD4SLC6A2HTR1D
Hydrochloric Acid SCHEMBL27499109 0.77 HTR2A (0.62) HTR2AHTR2CDRD4SLC6A2HTR1D
SCHEMBL2226775 0.77 GAA (0.64) HTR2AHTR2CPOLBGAAKDM4E
SCHEMBL5099895 0.76 HTR2A (0.55) HTR2AHTR2CDRD4SLC6A2HTR1D
SCHEMBL7027668 0.76 FABP1 (0.65) HTR2AHTR2CGAAMAPT
SCHEMBL5106532 0.75 PRKAA2 (0.64) HTR2AHTR2CPRKAA2KCNH2
SCHEMBL15109199 0.74 HTR2A (0.77) HTR2AHTR2CDRD4SLC6A2HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329749-B2 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GESELLSCHAFT (DE) 2008-02-12 US claimed
WO-2002057256-A9 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-12-08 WO claimed
EP-1366039-B1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-09-07 EP claimed
US-20040077657-A1 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GMBH (DE) 2004-04-22 US claimed
EP-1366039-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GmbH (DE) 2003-12-03 EP claimed
WO-2002057256-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2002-07-25 WO claimed
US-7329749-B2 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GESELLSCHAFT (DE) 2008-02-12 US disclosed
WO-2002057256-A9 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-12-08 WO disclosed
EP-1366039-B1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-09-07 EP disclosed
US-20040077657-A1 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GMBH (DE) 2004-04-22 US disclosed
EP-1366039-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GmbH (DE) 2003-12-03 EP disclosed
WO-2002057256-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077657-A1 Piperazinylcarbonylquinolines and -isoquinolines TPH2, HTR2C, HTR1A HTR2A 5/4885HTR2C 2/4885DRD4 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.